Back

Search with your voice

Play all

2021 CDER Small Business and Industry Assistance Webinars & Conferences

by U.S. Food and Drug Administration

•

Playlist•208 videos•23,706 views

Play all

Unavailable videos are hidden

PLAY ALL

2021 CDER Small Business and Industry Assistance Webinars & Conferences

208 videos

23,706 views

Last updated on Jul 11, 2024

Save playlist

Shuffle play

U.S. Food and Drug Administration

Play all

2021 CDER Small Business and Industry Assistance Webinars & Conferences

by U.S. Food and Drug Administration

Playlist•208 videos•23,706 views

Play all

42:44

Now playing

OTC Monograph Reform: OTC Sunscreen Drugs

U.S. Food and Drug Administration

•

4K views • 3 years ago

•

47:40

Now playing

OTC Monograph Reform: Deemed Final Orders

U.S. Food and Drug Administration

•

3.3K views • 3 years ago

•

1:27:24

Now playing

Clinical Investigator Training Course (CITC) Update - Operational Updates Part 2

U.S. Food and Drug Administration

•

1.6K views • 3 years ago

•

1:48:00

Now playing

Clinical Investigator Training Course (CITC) Update - Operational Updates Part 1

U.S. Food and Drug Administration

•

1.6K views • 3 years ago

•

1:23:07

Now playing

Clinical Investigator Training Course (CITC) Update - Scientific Updates Part 1

U.S. Food and Drug Administration

•

4.6K views • 3 years ago

•

1:33:32

Now playing

Pharmaceutical Quality Symposium 2021 Part 8 with Closing Remarks

U.S. Food and Drug Administration

•

796 views • 3 years ago

•

54:52

Now playing

Pharmaceutical Quality Symposium 2021 Part 7

U.S. Food and Drug Administration

•

920 views • 3 years ago

•

54:19

Now playing

Pharmaceutical Quality Symposium 2021 Part 6

U.S. Food and Drug Administration

•

872 views • 3 years ago

•

1:52:12

Now playing

Pharmaceutical Quality Symposium 2021 Part 5

U.S. Food and Drug Administration

•

1.9K views • 3 years ago

•

1:25:57

Now playing

Pharmaceutical Quality Symposium 2021 Part 4

U.S. Food and Drug Administration

•

1.6K views • 3 years ago

•

1:39:46

Now playing

Pharmaceutical Quality Symposium 2021 Part 3

U.S. Food and Drug Administration

•

2.3K views • 3 years ago

•

1:03:51

Now playing

Pharmaceutical Quality Symposium 2021 Part 2, FDA Leaders Panel Discussion

U.S. Food and Drug Administration

•

1.8K views • 3 years ago

•

1:58:48

Now playing

Pharmaceutical Quality Symposium 2021 Part 1 with Keynote Addresses

U.S. Food and Drug Administration

•

5.4K views • 3 years ago

•

1:47:29

Now playing

Electronic Drug Registration and Listing (eDRLS) Using CDER Direct Part 4 and Closing Remarks

U.S. Food and Drug Administration

•

3.1K views • 3 years ago

•

1:09:21

Now playing

Electronic Drug Registration and Listing (eDRLS) Using CDER Direct Part 3

U.S. Food and Drug Administration

•

2.1K views • 3 years ago

•

1:50:51

Now playing

Electronic Drug Registration and Listing (eDRLS) Using CDER Direct Part 2

U.S. Food and Drug Administration

•

4.5K views • 3 years ago

•

1:24:08

Now playing

Electronic Drug Registration and Listing (eDRLS) Using CDER Direct Part 1 with Keynote Address

U.S. Food and Drug Administration

•

9K views • 3 years ago

•

1:26:42

Now playing

Enhanced Drug Distribution Security in 2023 Under the DSCSA

U.S. Food and Drug Administration

•

5.6K views • 3 years ago

•

21:20

Now playing

Investigator Responsibilities - Safety Reporting for Investigational Drugs and Devices

U.S. Food and Drug Administration

•

2.3K views • 3 years ago

•

6:06

Now playing

Advancing Generic Drug Development: Translating Science to Approval, Day Two Closing Remarks

U.S. Food and Drug Administration

•

1.6K views • 3 years ago

•

1:31:52

Now playing

Complex Generics: Topical Products, Part 2

U.S. Food and Drug Administration

•

2K views • 3 years ago

•

1:57:52

Now playing

Complex Generics: Topical Products, Part 1

U.S. Food and Drug Administration

•

2.2K views • 3 years ago

•

1:51:52

Now playing

Complex Generics: Nasal and Inhalation Products

U.S. Food and Drug Administration

•

4.3K views • 3 years ago

•

1:59:34

Now playing

Cutting Edge Science in Complex Generics

U.S. Food and Drug Administration

•

1.1K views • 3 years ago

•

6:07

Now playing

Advancing Generic Drug Development: Translating Science to Approval, Day One Closing Remarks

U.S. Food and Drug Administration

•

477 views • 3 years ago

•

1:29:24

Now playing

Complex Generics: Complex Injectables, Ophthalmic, and Otic Products, Part 2

U.S. Food and Drug Administration

•

2.1K views • 3 years ago

•

1:25:59

Now playing

Complex Generics: Complex Injectables, Ophthalmic, and Otic Products, Part 1

U.S. Food and Drug Administration

•

2.4K views • 3 years ago

•

1:47:25

Now playing

Considerations in Assessing Generic Drug Products of Oral Dosage Forms

U.S. Food and Drug Administration

•

3.4K views • 3 years ago

•

1:48:13

Now playing

COVID-19 Impact on Generic Drug Regulation and Evaluation

U.S. Food and Drug Administration

•

1.2K views • 3 years ago

•

9:06

Now playing

Advancing Generic Drug Development: Translating Science to Approval Keynote Address

U.S. Food and Drug Administration

•

821 views • 3 years ago

•

57:18

Now playing

Promotional Submissions in eCTD Format - Grouped Submissions

U.S. Food and Drug Administration

•

3.1K views • 3 years ago

•

1:21:45

Now playing

Inspections and Use of Alternate Tools During the COVID-19 Public Health Emergency + Q/A Panel

U.S. Food and Drug Administration

•

1K views • 3 years ago

•

1:17:33

Now playing

Risk Management and Application Approaches in Responding to Supply Chain Constraints During PHE

U.S. Food and Drug Administration

•

1.1K views • 3 years ago

•

1:17:23

Now playing

FDA Guidance on Manufacturing During COVID-19 and High Absenteeism

U.S. Food and Drug Administration

•

2.3K views • 3 years ago

•

54:02

Now playing

OSI’s Role in the Drug Development Process and Impact of COVID-19

U.S. Food and Drug Administration

•

1.9K views • 3 years ago

•

31:16

Now playing

FDA Guidance on Conduct of Clinical Trials of Medical Products During the Public Health Emergency

U.S. Food and Drug Administration

•

2K views • 3 years ago

•

38:56

Now playing

Role of the Product Jurisdiction Team in the Medical Product Development Process

U.S. Food and Drug Administration

•

359 views • 3 years ago

•

26:21

Now playing

Regulatory Policy: Role in Guiding Decision Making in CDER

U.S. Food and Drug Administration

•

830 views • 3 years ago

•

19:50

Now playing

Communications in a Global Pandemic

U.S. Food and Drug Administration

•

302 views • 3 years ago

•

34:13

Now playing

Communication Best Practices – Interacting with Regulatory Project Managers in CDER/ORO

U.S. Food and Drug Administration

•

1.6K views • 3 years ago

•

39:09

Now playing

Where Do We Go from Here? How the Ombudsman Can Help

U.S. Food and Drug Administration

•

635 views • 3 years ago

•

1:18:40

Now playing

CDER’s Role in Public Health Emergency Response and Medical Countermeasure Development

U.S. Food and Drug Administration

•

571 views • 3 years ago

•

37:46

Now playing

Clinical Pharmacology Regulatory Sciences in Drug Development and Precision Medicine

U.S. Food and Drug Administration

•

3.4K views • 3 years ago

•

37:28

Now playing

Strategies to Address Potential Medication Errors for EUA Products for COVID-19

U.S. Food and Drug Administration

•

504 views • 3 years ago

•

40:14

Now playing

Product Quality Consideration for Emergency Use Authorizations (EUAs)

U.S. Food and Drug Administration

•

847 views • 3 years ago

•

46:23

Now playing

Electronic Common Technical Document (eCTD)

U.S. Food and Drug Administration

•

12K views • 3 years ago

•

22:17

Now playing

CDER NextGen Portal

U.S. Food and Drug Administration

•

2.4K views • 3 years ago

•

29:10

Now playing

Resource Capacity Planning: How CDER is Modernizing Resource Planning Capabilities

U.S. Food and Drug Administration

•

251 views • 3 years ago

•

4:21

Now playing

ANDA Efforts Related to COVID-19

U.S. Food and Drug Administration

•

395 views • 3 years ago

•

41:25

Now playing

OND Reorganization and the New Drugs Regulatory Program Modernization

U.S. Food and Drug Administration

•

1K views • 3 years ago

•

1:09:45

Now playing

Plenary Session

U.S. Food and Drug Administration

•

619 views • 3 years ago

•

18:56

Now playing

2021 REdI Conference Keynote Address by Janet Woodcock, MD

U.S. Food and Drug Administration

•

1K views • 3 years ago

•

1:14:28

Now playing

In Vitro and In Vivo BE Approaches: Challenges and Opportunities – Session 3A

U.S. Food and Drug Administration

•

2.3K views • 3 years ago

•

4:18

Now playing

Closing Remarks

U.S. Food and Drug Administration

•

677 views • 3 years ago

•

1:16:01

Now playing

In Vitro and In Vivo BE Approaches: Challenges and Opportunities – Session 3B

U.S. Food and Drug Administration

•

1.2K views • 3 years ago

•

1:33:54

Now playing

Complex Product Characterization/Analysis - Session 2C

U.S. Food and Drug Administration

•

1.2K views • 3 years ago

•

32:50

Now playing

Complex Product Characterization/Analysis - Session 2B

U.S. Food and Drug Administration

•

1.1K views • 3 years ago

•

34:41

Now playing

Complex Product Characterization/Analysis - Session 2A

U.S. Food and Drug Administration

•

1.5K views • 3 years ago

•

1:01:02

Now playing

Model-Integrated Evidence for Generic Drug Development – Session 1C

U.S. Food and Drug Administration

•

683 views • 3 years ago

•

50:27

Now playing

Model-Integrated Evidence for Generic Drug Development – Session 1B

U.S. Food and Drug Administration

•

1.4K views • 3 years ago

•

50:54

Now playing

Model-Integrated Evidence for Generic Drug Development – Session 1A

U.S. Food and Drug Administration

•

564 views • 3 years ago

•

53:19

Now playing

Panel Discussion with Generic Industry - GDUFA Science and Research Initiatives Public Workshop

U.S. Food and Drug Administration

•

403 views • 3 years ago

•

20:39

Now playing

Public Comment - GDUFA Science and Research Initiatives Public Workshop

U.S. Food and Drug Administration

•

423 views • 3 years ago

•

1:22:09

Now playing

Generic Industry Challenge Perspectives - GDUFA Science and Research Initiatives Public Workshop

U.S. Food and Drug Administration

•

1.3K views • 3 years ago

•

1:21:44

Now playing

Keynote and Industry Survey Results - GDUFA Science and Research Initiatives Public Workshop

U.S. Food and Drug Administration

•

785 views • 3 years ago

•

35:38

Now playing

Safety Reporting Requirements and Safety Assessment for IND and BA/BE Studies

U.S. Food and Drug Administration

•

8.8K views • 3 years ago

•

1:27:00

Now playing

Identification of Medicinal Products: Path to Global Implementation

U.S. Food and Drug Administration

•

4.4K views • 3 years ago

•

7:31:34

Now playing

FDA Regulatory Education for Industry (REdI) – Biologics Track

U.S. Food and Drug Administration

•

9.7K views • Streamed 3 years ago

•

8:58:15

Now playing

FDA Regulatory Education for Industry (REdI) – Devices and Biologics Track

U.S. Food and Drug Administration

•

8.2K views • Streamed 3 years ago

•

7:31:31

Now playing

FDA Regulatory Education for Industry (REdI) – Devices Track

U.S. Food and Drug Administration

•

10K views • Streamed 3 years ago

•

49:29

Now playing

OTC Monograph Drug User Fee Program (OMUFA): Understanding FY 2021 User Fees

U.S. Food and Drug Administration

•

2K views • 3 years ago

•

21:18

Now playing

ANDA Labeling: Helpful Hints and Resources

U.S. Food and Drug Administration

•

1.7K views • 3 years ago

•

12:57

Now playing

Product Specific Guidances Webinar – Opening Remarks

U.S. Food and Drug Administration

•

2.1K views • 3 years ago

•

1:26:22

Now playing

FDA Study Data Technical Rejection Criteria (TRC): What you need to know!

U.S. Food and Drug Administration

•

4.7K views • 3 years ago

•

1:03:29

Now playing

FDA and Health Canada Regional ICH Consultation Part II

U.S. Food and Drug Administration

•

941 views • 3 years ago

•

1:29:33

Now playing

FDA and Health Canada Regional ICH Consultation Part I

U.S. Food and Drug Administration

•

1.8K views • 3 years ago

•

4:55

Now playing

Product Specific Guidances - Closing Remarks

U.S. Food and Drug Administration

•

207 views • 3 years ago

•

17:43

Now playing

Controlled Correspondence Related to Pharmaceutical Quality

U.S. Food and Drug Administration

•

1.3K views • 3 years ago

•

55:25

Now playing

Common Labeling Deficiencies and Tips for Generic Drug Applications

U.S. Food and Drug Administration

•

3K views • 3 years ago

•

1:02:16

Now playing

Panel Discussion on Product-Specific Guidances

U.S. Food and Drug Administration

•

1.3K views • 3 years ago

•

19:15

Now playing

Bioequivalence Regulations and Product-Specific Guidances

U.S. Food and Drug Administration

•

3.3K views • 3 years ago

•

21:11

Now playing

Developing and Implementing Science-Based Standards in Bioequivalence Assessment

U.S. Food and Drug Administration

•

810 views • 3 years ago

•

14:41

Now playing

Product-Specific Guidance Fundamentals from a Clinical Perspective

U.S. Food and Drug Administration

•

668 views • 3 years ago

•

19:10

Now playing

Product-Specific Guidances for Complex Generic Drugs

U.S. Food and Drug Administration

•

1.4K views • 3 years ago

•

20:00

Now playing

Non-Complex Drug Products and Product-Specific Guidances

U.S. Food and Drug Administration

•

770 views • 3 years ago

•

13:21

Now playing

Overview of the FDA Product-Specific Guidance Program

U.S. Food and Drug Administration

•

1.6K views • 3 years ago

•

30:56

Now playing

Panel Discussion

U.S. Food and Drug Administration

•

258 views • 3 years ago

•

22:52

Now playing

ANDA Postapproval Changes: Best Practices and Strategies to Avoid Common Quality Assessment Issues

U.S. Food and Drug Administration

•

5.2K views • 3 years ago

•

15:11

Now playing

Update on Shared System REMS for Generic Drugs

U.S. Food and Drug Administration

•

783 views • 3 years ago

•

24:08

Now playing

Premarket Review of Expedited Serious Adverse Event Reports of BA/BE Studies

U.S. Food and Drug Administration

•

712 views • 3 years ago

•

14:52

Now playing

Postmarketing Safety and Surveillance of Generic Drugs Update

U.S. Food and Drug Administration

•

1.1K views • 3 years ago

•

30:18

Now playing

Panel Discussion

U.S. Food and Drug Administration

•

337 views • 3 years ago

•

23:39

Now playing

Building a Better Sterility Assurance Application

U.S. Food and Drug Administration

•

768 views • 3 years ago

•

22:47

Now playing

Integrated Manufacturing Assessment: Expectations

U.S. Food and Drug Administration

•

378 views • 3 years ago

•

21:57

Now playing

Biopharmaceutics Risk Assessment to Guide Dissolution Method Development for Solid Oral Dosage Forms

U.S. Food and Drug Administration

•

3.8K views • 3 years ago

•

24:45

Now playing

Panel Discussion

U.S. Food and Drug Administration

•

336 views • 3 years ago

•

31:55

Now playing

Assessment of Extractables/Leachables Data in ANDA Submissions

U.S. Food and Drug Administration

•

8.3K views • 3 years ago

•

19:58

Now playing

Lab Science to Support Generic Complex Drug Product Assessment

U.S. Food and Drug Administration

•

310 views • 3 years ago

•

15:15

Now playing

Fostering Innovation Through OPQ’s Emerging Technology Program

U.S. Food and Drug Administration

•

133 views • 3 years ago

•

100

18:40

Now playing

Panel Discussion

U.S. Food and Drug Administration

•

144 views • 3 years ago

•

…

NaN / NaN